# A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients

> **NCT00613652** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 30 (estimated)

## Conditions studied

- Cancer
- Tumors
- Carcinoma

## Interventions

- **DRUG:** AZD4877

## Key facts

- **NCT ID:** NCT00613652
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613652, "A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00613652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*